Clive A. Meanwell
2011
In 2011, Clive A. Meanwell earned a total compensation of $4.1M as Chairman and Chief Executive Officer at Medicines, a 64% increase compared to previous year.
Compensation breakdown
| Bonus | $676,062 |
|---|---|
| Option Awards | $1,840,050 |
| Salary | $723,060 |
| Stock Awards | $837,600 |
| Other | $1,794 |
| Total | $4,078,566 |
Meanwell received $1.8M in option awards, accounting for 45% of the total pay in 2011.
Meanwell also received $676.1K in bonus, $723.1K in salary, $837.6K in stock awards and $1.8K in other compensation.
Rankings
In 2011, Clive A. Meanwell's compensation ranked 1,405th out of 10,747 executives tracked by ExecPay. In other words, Meanwell earned more than 86.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,405 out of 10,747 | 87th |
Division Manufacturing | 523 out of 3,960 | 87th |
Major group Chemicals And Allied Products | 114 out of 1,033 | 89th |
Industry group Drugs | 64 out of 781 | 92nd |
Industry Pharmaceutical Preparations | 54 out of 571 | 91st |
Source: SEC filing on April 30, 2014.
Meanwell's colleagues
We found four more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2011.